Back to GA Gotham Asset Management, LLC
CORT
Showing 8 of 31 quarters
Position history for GAGotham Asset Management, LLC's holdings in Corcept Therapeutics Incorporated.
Yes. Gotham Asset Management holds 60,181 shares of CORT (Corcept Therapeutics), worth $5.2M, as of its Q2 2026 13F filing. It increased the position from 17,918 shares in Q1 2026. Gotham Asset Management has held CORT in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$5.2M
Current Shares
60,181
Total Value Change
+$4.4M
Total Shares Change
+41,567
Quarter-by-Quarter History